Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Effects in Dot-Probe Attention Bias Modification (ABM) Among Adults With Social Anxiety Disorder.

NCT07666776 is registered in ClinicalTrials.gov with Tel Aviv University as lead sponsor.

NCT NCT07666776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07666776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Effects in Dot-Probe Attention Bias Modification (ABM) Among Adults With Social Anxiety Disorder.
Lead sponsor
Tel Aviv University
Phase
Not applicable
Overall status
Recruiting
Start date
June 15, 2026
Completion date
June 30, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention bias modification treatment (abmt), placebo effect, social anxiety disorder (sad)